Market Indices
Sector Heatmap
BIO.B — Bio-Rad Laboratories, Inc. Class B
NYSEBio-Rad Laboratories, Inc. Class B
- O
- 365.08
- H
- 365.08
- L
- 365.08
- V
- 103.15
Chart
About BIO.B
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Key Financial Statistics
| Market Cap | N/A |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $244.54 - $365.08 |
| 52-Week Avg Volume | 68.347 |
| VWAP | $367.84 |
| Transactions | 24 |
| Total Recorded Bars | 6,747 days |